| Status | Study |
| Completed |
Study Name: Clinical Grade Adenovirus Specific T Cells for Immunotherapy After Allogeneic Stem Cell Transplantation (CTL-ADV) Condition: Adenovirus Infection Date: 2016-07-28 Interventions: Other: Infusion of ADV specific T cells Cell engineering |
| Recruiting |
Study Name: Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine Condition: Acquired Immunodeficiency Syndrome Date: 2016-05-02 Interventions: Biological: Ad5-gag Ad5-gag is |
| Recruiting |
Study Name: Virus-specific ImmunoTherapy Following Allogeneic Stem Cell Transplantation Condition: Cytomegalovirus Infection Adenovirus Infection Date: 2016-03-01 Interventions: Biological: virus-specific T-Cells infusion |
| Available |
Study Name: Expanded Access Protocol to Provide Brincidofovir for the Treatment of Serious Adenovirus Infection or Disease Condition: Adenovirus Date: 2015-11-03 Interventions: Drug: Brincidofovir Up to 100mg Brincidofovir twice weekly, not to exceed a total dose of 200mg each wee |
| Terminated |
Study Name: A Multicenter Study to Obtain Retrospective Data for Subjects Previously Diagnosed With Adenovirus Infection to Serve as Matched Historical Controls for Study CMX001-304 Condition: Adenovirus Date: 2015-04-09 Interventions: Drug: Brincidofovir Rates of adenovirus progression and mortality in subjects with adenovirus infection |
| Not yet recruiting |
Study Name: Phase 1 Clinical Trial to Evaluate the Safety and Immunogenicity of an Adenovirus-based Tuberculosis Vaccine Administered by Aerosol Condition: Tuberculosis Date: 2014-12-19 Interventions: Biological: Ad5Ag85A |
| Not yet recruiting |
Study Name: Most Closely Human Leukocyte Antigen (HLA)-Matched Adenovirus-specific T Lymphocytes (Viralym-A) Condition: Adenovirus Infection Date: 2014-10-20 Interventions: Biological: Viralym-A Follow-up Assessments: The timing of |
| Completed |
Study Name: Phase III, Open-labeled, Multicenter Study of the Safety and Efficacy of Brincidofovir (CMX001) in the Treatment of Early Versus Late Adenovirus Infection Condition: Adenovirus Infection Date: 2014-03-12 Interventions: Drug: CMX001 CMX001 administered twice weekly, dose depending on weight. |
| Completed |
Study Name: Ad Sensor-based Real-time Diagnosis of Adenovirus Condition: Adenovirus Date: 2013-12-06 Interventions: Device: Ad sensor Ad sensor, which was developed for the r |
| Not yet recruiting |
Study Name: Phase I Endovenous Administration of Oncolytic Adenovirus ICOVIR-5 in Patients With Advanced or Metastatic Melanoma Condition: Locally Advanced or Metastatic Melanoma Date: 2013-05-22 Interventions: Biological: ICOVIR-5 |